Table 1.
European Randomized Study of Screening for Prostate Cancer (ERSPC) Results
| Study Participants | Cancer Incidence | Cancer Mortality | ||
| Total, age 55–69 years | 162,243 | 10,297 | ||
| Screening group | 72,890 (44.9%) | 5990 (8.2%) | 214 | 0.80* |
| Control group | 89,353 (55.1%) | 4307 (4.8%) | 326 |
95% confidence interval, 0.67–0.95; P = .01.
Data from Schröder FH et al.1